Trump Administration’s Funding Freeze Sparks Legal Battles and Raises Concerns for Scientific Research
During its initial week, the Trump administration instituted a “temporary pause” on billions of dollars in funding that had already been approved by Congress, impacting essential services in areas like education, healthcare, and scientific research. This abrupt action led numerous states and federal grantees to file lawsuits, challenging the limits of executive power.
Federal courts have ruled against the unrestricted funding freeze, deeming it unlawful as presidents cannot indiscriminately stop funding already sanctioned by Congress. This decision has temporarily restored some funds, yet uncertainty looms for those dependent on this financial support, particularly in the fields of science, technology, and innovation.
The administration’s early directive is just one method it has employed to undermine funding for scientific research. Since taking office, attempts have been made to cancel over 7,000 grants from the National Institutes of Health and the National Science Foundation, two pivotal sources for biomedical and science and engineering research, respectively. These grants collectively represent more than $3 billion, according to data tracked by Grant Witness. Furthermore, the administration proposed even more severe cuts amounting to $44 billion in research and development funding for the upcoming fiscal year.
Arati Prabhakar, recently serving as President Biden’s chief advisor for science and technology, and former director of the White House Office of Science and Technology Policy, has actively engaged in one of the lawsuits, New York v. Trump, by submitting a friend-of-the-court brief. With a Ph.D. in applied physics and experience leading research agencies, Prabhakar underscores the critical need for consistent federal funding to maintain America’s scientific leadership and secure the well-being of its citizens.
As the First Circuit Court of Appeals prepares for the New York v. Trump oral arguments on November 18, Prabhakar shared insights on the funding freeze and its implications with journalist Kendall Verhovek.
Verhovek: Why did you feel compelled to get involved in this case?
Arati Prabhakar: I’ve dedicated my career to advancing science, technology, and innovation in both government and Silicon Valley. The idea of submitting an amicus brief was unexpected for me, but we are facing a crisis. The immediate harms from the funding freeze are concerning, but the long-term impact of halting federal research investments could mean forfeiting our future.
Verhovek: What concerns do you have regarding the administration’s broader effort to reduce science funding?
Prabhakar: The consequences are dire—clinical trials for cancer patients have been halted, defunded satellite missions and climate centers mean reduced data for farmers, and under-resourced health departments may fail to detect foodborne diseases. These cuts impact immediate lives and obstruct future advances in vital areas like energy and health.
Historically, American innovation, like the GPS technology originating from efforts to track Sputnik, has resulted from collective investment in science. Such bold action is essential for our future, and we risk losing this creative momentum.
Verhovek: How does the funding freeze connect to other administration actions?
Prabhakar: The attack on America’s science and technology infrastructure is part of a broader threat to democracy. The rule of law is fundamental, extending to essential scientific research for security, health, and prosperity. Our federal research and development enterprise, supported by bipartisan commitment for decades, is under threat.
Verhovek: Can the private sector compensate if the funding freeze is upheld?
Prabhakar: No, the private sector focuses on profit-driven research and development. Basic research often lacks profitability for individual companies but remains essential for industries and the economy. The federal government plays a crucial role in research for public purposes, such as environmental studies.
Verhovek: Is there room for improving American science?
Prabhakar: While federally funded research isn’t perfect, it is indispensable. My work in public service has always aimed at harnessing our nation’s capabilities to address future challenges. Much progress has been undone, necessitating immediate action to end this crisis and rebuild for a more effective future.
